A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people. The results were presented at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium held in San ...

With colorectal cancer a growing concern among younger people, the American Cancer Society has endorsed two new types of stool tests to encourage people to get screened, while also recommending a limited role for new blood tests that many patients find ...

A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test aims to find fragments of DNA in a person’s blood that ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy result. GRAIL, the company behind Galleri, recently ...

The most common type of colon cancer is adenocarcinoma, which usually has a favorable outcome if diagnosed and treated early. Screening is an important tool for a prompt diagnosis. Colorectal cancer is the fourth most common type of cancer in the United ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Some companies now offer multi-cancer early detection tests designed to screen for multiple cancers at once.

Wall Street's newest cancer bet isn't about finding tumors early, but about making sure they're really gone. The Wall Street Journal reports on Natera, a company based in Austin, Texas, that has quietly come to dominate "minimal residual disease" (MRD) testing,

The American Cancer Society is updating its guidelines to include a new screening for the most frequently diagnosed cancer. A blood test is now an option when getting checked